These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37687229)

  • 1. The Anti-Breast Cancer Stem Cell Potency of Copper(I)-Non-Steroidal Anti-Inflammatory Drug Complexes.
    Johnson A; Feng X; Singh K; Ortu F; Suntharalingam K
    Molecules; 2023 Sep; 28(17):. PubMed ID: 37687229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating the Chemical and Biological Properties of Cancer Stem Cell-Potent Copper(II)-Nonsteroidal Anti-Inflammatory Drug Complexes.
    Shin J; Eskandari A; Suntharalingam K
    Molecules; 2019 Apr; 24(9):. PubMed ID: 31035718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes.
    Boodram JN; Mcgregor IJ; Bruno PM; Cressey PB; Hemann MT; Suntharalingam K
    Angew Chem Int Ed Engl; 2016 Feb; 55(8):2845-50. PubMed ID: 26806362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles.
    Eskandari A; Boodram JN; Cressey PB; Lu C; Bruno PM; Hemann MT; Suntharalingam K
    Dalton Trans; 2016 Nov; 45(44):17867-17873. PubMed ID: 27774561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioinspired redox-modulating copper(II)-macrocyclic complex bearing non-steroidal anti-inflammatory drugs with anti-cancer stem cell activity.
    Johnson A; Iffland-Mühlhaus L; Northcote-Smith J; Singh K; Ortu F; Apfel UP; Suntharalingam K
    Dalton Trans; 2022 Apr; 51(15):5904-5912. PubMed ID: 35348171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reactive oxygen species-generating, cancer stem cell-potent manganese(ii) complex and its encapsulation into polymeric nanoparticles.
    Eskandari A; Suntharalingam K
    Chem Sci; 2019 Sep; 10(33):7792-7800. PubMed ID: 31588328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-breast cancer stem cell properties of gold(i)-non-steroidal anti-inflammatory drug complexes.
    Johnson A; Olelewe C; Kim JH; Northcote-Smith J; Mertens RT; Passeri G; Singh K; Awuah SG; Suntharalingam K
    Chem Sci; 2023 Jan; 14(3):557-565. PubMed ID: 36741517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Cancer Stem Cell Potency of Nickel(II)-Polypyridyl Complexes Containing Non-steroidal Anti-inflammatory Drugs.
    Feld CJ; Johnson A; Xiao Z; Suntharalingam K
    Chemistry; 2020 Nov; 26(61):14011-14017. PubMed ID: 32485001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum-Targeting Copper(II) Complex.
    Kaur P; Johnson A; Northcote-Smith J; Lu C; Suntharalingam K
    Chembiochem; 2020 Dec; 21(24):3618-3624. PubMed ID: 32776422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell activity of copper(II)-terpyridine complexes with aryl sulfonamide groups.
    Singh K; Northcote-Smith J; Singh K; Suntharalingam K
    Dalton Trans; 2023 Jul; 52(28):9694-9704. PubMed ID: 37386843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bulk Breast Cancer Cell and Breast Cancer Stem Cell Activity of Binuclear Copper(II)-Phenanthroline Complexes.
    Osei PB; Northcote-Smith J; Fang J; Singh K; Ortu F; Suntharalingam K
    Chemistry; 2023 Aug; 29(45):e202301188. PubMed ID: 37249243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunogenic anti-cancer stem cell bi-nuclear copper(II)-flufenamic acid complex.
    Li Y; Fang J; Singh K; Ortu F; Suntharalingam K
    Dalton Trans; 2024 Apr; 53(14):6410-6415. PubMed ID: 38501501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypyridyl Zinc(II)-Indomethacin Complexes with Potent Anti-Breast Cancer Stem Cell Activity.
    Rundstadler TK; Eskandari A; Norman SM; Suntharalingam K
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30181492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Breast Cancer Stem Active Cobalt(III)-Cyclam Complex Containing Flufenamic Acid with Immunogenic Potential.
    Fang J; Orobator ON; Olelewe C; Passeri G; Singh K; Awuah SG; Suntharalingam K
    Angew Chem Int Ed Engl; 2024 Feb; 63(6):e202317940. PubMed ID: 38063406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Stem Cell and Bulk Cancer Cell Active Copper(II) Complexes with Vanillin Schiff Base Derivatives and Naproxen.
    Lu C; Eskandari A; Cressey PB; Suntharalingam K
    Chemistry; 2017 Aug; 23(47):11366-11374. PubMed ID: 28658520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cobalt(III)-Macrocyclic Scaffolds with Anti-Cancer Stem Cell Activity.
    Fang J; Gerschel P; Singh K; Apfel UP; Suntharalingam K
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Copper(II) Phenanthroline Metallopeptide That Targets and Disrupts Mitochondrial Function in Breast Cancer Stem Cells.
    Laws K; Bineva-Todd G; Eskandari A; Lu C; O'Reilly N; Suntharalingam K
    Angew Chem Int Ed Engl; 2018 Jan; 57(1):287-291. PubMed ID: 29144008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
    Laws K; Eskandari A; Lu C; Suntharalingam K
    Chemistry; 2018 Oct; 24(57):15205-15210. PubMed ID: 30052298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
    Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
    J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.